Cybin (HELP) Cash & Equivalents (2020 - 2024)
Cybin (HELP) reported Cash & Equivalents of $149.6 million for Q4 2024, up 1124.53% on a YoY basis from $12.2 million in Q1 2024, and up 32.25% quarter-over-quarter from $113.1 million in Q3 2024.
Cybin (HELP) Cash & Equivalents (2020 - 2024) Analysis & Trends
Cybin has reported Cash & Equivalents for 5 years, with the latest figure at $149.6 million in Q4 2024.
- For the quarter ending Q4 2024, Cash & Equivalents rose 1124.53% year-over-year to $149.6 million; the trailing twelve-month figure through Dec 2024 stood at $149.6 million (up 1124.53% YoY), and the FY2024 full-year result was $155.1 million, changed N/A from the prior year.
- Cash & Equivalents for Q4 2024 stood at $149.6 million, up from $113.1 million in the prior quarter.
- The five-year high for Cash & Equivalents was $155.1 million in Q1 2024, with the low at $1.1 million in Q2 2020.
- Historically, Cash & Equivalents has averaged $51.5 million across 5 years, with a median of $39.5 million in 2022.
- Annual changes were most pronounced in 2021 — Cash & Equivalents jumped 4574.57% — and 2023, when it sank 69.83%.
- Cybin's Cash & Equivalents stood at $3.0 million in 2020, then surged by 1910.21% to $59.6 million in 2021, then plunged by 33.74% to $39.5 million in 2022, then sank by 69.08% to $12.2 million in 2023, then surged by 1124.53% to $149.6 million in 2024.
- The last three Cash & Equivalents figures came in at $149.6 million (Q4 2024), $113.1 million (Q3 2024), and $152.8 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 558.94 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 149.61 Mn |
| Sep 30, 2024 | 113.12 Mn |
| Jun 30, 2024 | 152.80 Mn |
| Mar 31, 2024 | 155.10 Mn |
| Dec 31, 2023 | 12.22 Mn |
| Sep 30, 2023 | 12.41 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Feb 28, 2023 | 30.15 Mn |
| Dec 31, 2022 | 39.52 Mn |
| Sep 30, 2022 | 41.13 Mn |
| May 31, 2022 | 31.99 Mn |
| Feb 28, 2022 | 4.54 Mn |
| Dec 31, 2021 | 59.64 Mn |
| Sep 30, 2021 | 50.86 Mn |
| Jun 30, 2021 | 52.09 Mn |
| Mar 31, 2021 | 50.59 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Sep 30, 2020 | 5.78 Mn |
| Jun 30, 2020 | 1.11 Mn |